Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
about
JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinomaSustained JNK1 activation is associated with altered histone H3 methylations in human liver cancerThe IKK complex contributes to the induction of autophagyCD95 promotes tumour growthJNK Signaling: Regulation and Functions Based on Complex Protein-Protein PartnershipsThe NF-κB Pathway and Cancer Stem CellsRegulatory Roles of MAPK Phosphatases in CancerInteractions between Myc and Mediators of Inflammation in Chronic Liver DiseasesThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseTargeting RTK Signaling Pathways in CancerEmerging role of Toll-like receptor 4 in hepatocellular carcinomaAre hematopoietic stem cells involved in hepatocarcinogenesis?Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseasesJNK signalling in cancer: in need of new, smarter therapeutic targetsRole of innate immunity in the development of hepatocellular carcinomaThe stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesisDivergent effects of PERK and IRE1 signaling on cell viabilityHCV Tumor Promoting Effect Is Dependent on Host Genetic BackgroundStructural and functional analysis of the natural JNK1 inhibitor quercetagetinActivation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinomaMolecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKNF-κB, JNK, and TLR Signaling Pathways in HepatocarcinogenesisInflammation- and stress-related signaling pathways in hepatocarcinogenesisThe NIEHS Superfund Research Program: 25 Years of Translational Research for Public HealthA liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaJNK-induced apoptosis, compensatory growth, and cancer stem cellsTAK1 binding protein 2 is essential for liver protection from stressorsGender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionLoss of SPARC in bladder cancer enhances carcinogenesis and progression.The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activationApplication of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma.Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammationHepatocyte death: a clear and present danger.Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology GroupActivation of c-Jun N-terminal kinase (JNK) during mitosis in retinal progenitor cells.
P2860
Q23919676-93B99212-F859-4AB5-8667-96335F474BA5Q24170091-A7ABE21F-69A5-4556-B967-A563766DCE23Q24329117-9D3DBDC3-3A5B-47C1-B225-6EB05A25D4C2Q24602589-12C75208-A9A5-46EC-A7A1-F8C2BB2A710FQ26741279-468B3B43-5183-4CDE-B537-9FD1417DE48AQ26750605-23F50203-1FF7-4E5D-96B0-FBC3913ECFD3Q26751025-B8B8EEA0-7708-46E4-B72E-ACEBBC56AEE5Q26778328-4E9D1781-05A9-4045-845C-B0FBFDD8AF3DQ26780509-1104A1DF-1B12-4BDC-AF03-EAD906C878DAQ26781278-F7BEB6BF-D402-43E7-AA16-D592D86C9845Q26824613-9A4761FA-8DEB-4886-BAEA-082438470C60Q26830307-A8CC2E2F-3999-4C8C-BD93-496B20D335BEQ26863522-B55C57AD-C40E-4B0A-A03F-7F581B22C7DCQ27023869-930099CD-BBA1-41A4-AA37-F0334E38A1C1Q27024780-1B8A70CB-83A8-48B0-9694-98E4632EAD4AQ27319729-FC27A89C-A6C8-4CED-9309-4A341596B1FBQ27438124-5C8AB67F-C6F6-435B-948F-A06CFD069447Q27488251-513CA335-A845-42CA-AD1B-089FB77C25FCQ27675046-24744001-FF65-4FE3-89C6-105AEC04CBA1Q27851797-0F4111C4-C1ED-4783-A708-0938CD619434Q28384866-15FF1657-73A9-4CBE-9296-EC2FE390272DQ28384956-4D1D2919-3F0A-4802-B573-20E60845563EQ28387669-EA8E3CDA-C8E3-4943-BC22-3066F6AF93BBQ28390083-740B7A86-20A5-4A97-9ED4-8E4795CF8F56Q28392033-C36BA0E4-607E-4D9F-AC5A-3BFC2FB59B59Q28392224-11ACAE3A-AF88-4F4E-A2BE-EB352BCC167CQ28395713-07661511-9CFF-4F34-A6E1-48D6855CE9B9Q28539471-BF458B4B-8DD5-4B3F-8E94-E4B7206A69F2Q29614596-4885BB32-6E43-4B78-A31E-884094CD967EQ29615766-7ACA23B4-C7DF-45F7-B5C3-20743BEFB517Q30422650-3077A926-E43D-46E2-A3B5-5125E858AAE4Q30500831-50F0D3E6-4398-45AA-BEBE-2C4B3DAD641EQ33640296-44E834B4-35CC-4DFD-8B7C-67B74732B679Q33703030-041F5077-8996-40E8-ABBF-B09EBA5E9FFAQ33737707-DF640B5F-642A-47CC-9751-F36C9F883DECQ33846407-EB11A3D0-4ADE-491F-839B-C78D0EC9C946Q34028645-3C936F81-96A0-44FD-BE66-5B2ADCE298C3Q34147508-9397CA4D-3122-4986-B91D-8E832DD6F035Q34225158-7864A95A-1DF2-467A-9337-CAC661525BA7Q34230126-3D4002A0-CB4D-43CC-8F87-DE10745BA060
P2860
Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@ast
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@en
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@nl
type
label
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@ast
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@en
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@nl
prefLabel
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@ast
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@en
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@nl
P2093
P2860
P356
P1476
Loss of hepatic NF-kappa B act ...... N-terminal kinase 1 activation
@en
P2093
Lufen Chang
Shin Maeda
Toshiharu Sakurai
P2860
P304
10544-10551
P356
10.1073/PNAS.0603499103
P407
P577
2006-06-28T00:00:00Z